These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3891469

  • 1. Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin.
    Haneda M, Kobayashi M, Maegawa H, Watanabe N, Takata Y, Ishibashi O, Shigeta Y, Inouye K.
    Diabetes; 1985 Jun; 34(6):568-73. PubMed ID: 3891469
    [Abstract] [Full Text] [Related]

  • 2. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M, Haneda M, Maegawa H, Watanabe N, Takada Y, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):49-57. PubMed ID: 6367745
    [Abstract] [Full Text] [Related]

  • 3. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.
    Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H.
    Proc Natl Acad Sci U S A; 1983 Dec 29; 80(24):7390-4. PubMed ID: 6424111
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE, Abram JD, Frank BH, Duckworth WC.
    Endocrinology; 1984 May 29; 114(5):1818-24. PubMed ID: 6370667
    [Abstract] [Full Text] [Related]

  • 6. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET.
    Proc Natl Acad Sci U S A; 1980 Jun 29; 77(6):3181-5. PubMed ID: 6997872
    [Abstract] [Full Text] [Related]

  • 7. Lysosomal degradation of receptor-bound 125I-labeled insulin by rat adipocytes: its characterization and dissociation from the short-term biologic effects of insulin.
    Hammons GT, Jarett L.
    Diabetes; 1980 Jun 29; 29(6):475-86. PubMed ID: 6991335
    [Abstract] [Full Text] [Related]

  • 8. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
    Yonezawa K, Yokono K, Shii K, Hari J, Yaso S, Sakamoto T, Kawase Y, Akiyama H, Taketomi S, Baba S.
    Endocrinology; 1989 Jan 29; 124(1):496-504. PubMed ID: 2642422
    [Abstract] [Full Text] [Related]

  • 9. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE, Lu ZX, Parlautan L, Lynch CS, Weiss MA.
    Biochemistry; 1992 Feb 18; 31(6):1757-67. PubMed ID: 1737029
    [Abstract] [Full Text] [Related]

  • 10. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM.
    Diabetes Care; 1981 Feb 18; 4(2):244-7. PubMed ID: 7011736
    [Abstract] [Full Text] [Related]

  • 11. [LeuB24]- and [LeuB25]insulins are not antagonists of lipogenesis in adipocytes.
    Diaconescu C, Saunders D, Gattner HG, Brandenburg D.
    Hoppe Seylers Z Physiol Chem; 1982 Feb 18; 363(2):187-92. PubMed ID: 7037593
    [Abstract] [Full Text] [Related]

  • 12. Photoreactive insulin derivatives. Comparison of biologic activity and labeling properties of three analogues in isolated rat adipocytes.
    Wang CC, Hedo JA, Kahn CR, Saunders DT, Thamm P, Brandenburg D.
    Diabetes; 1982 Dec 18; 31(12):1068-76. PubMed ID: 6757019
    [No Abstract] [Full Text] [Related]

  • 13. Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin.
    Kobayashi M, Takata Y, Ishibashi O, Sasaoka T, Iwasaki TM, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1986 May 29; 137(1):250-7. PubMed ID: 3521604
    [Abstract] [Full Text] [Related]

  • 14. Pathways of insulin degradation in isolated adipocytes: evaluation by gel filtration and differential precipitation.
    Kahn CR, Baird KL.
    Metabolism; 1985 Apr 29; 34(4):354-63. PubMed ID: 3884964
    [Abstract] [Full Text] [Related]

  • 15. [Biochemical characteristics of an initial degradation product of insulin by insulin-degrading enzyme].
    Yonezawa K.
    Nihon Naibunpi Gakkai Zasshi; 1988 Nov 20; 64(11):1140-56. PubMed ID: 2851464
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC, Zong L, Burke GT, Katsoyannis PG.
    J Protein Chem; 1992 Oct 20; 11(5):571-7. PubMed ID: 1360216
    [Abstract] [Full Text] [Related]

  • 18. Effect of cross-linking agents on insulin associated responses in adipocytes.
    Goren HJ, Kahn CR.
    Can J Biochem; 1982 Oct 20; 60(10):987-1000. PubMed ID: 6756618
    [Abstract] [Full Text] [Related]

  • 19. The effect of triiodothyronine on insulin binding and action in rat adipocytes.
    Cech JM, Amatruda JM.
    Horm Metab Res; 1983 Nov 20; 15(11):530-2. PubMed ID: 6360843
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes.
    Peavy DE, Abram JD, Frank BH, Duckworth WC.
    Diabetes; 1984 Nov 20; 33(11):1062-7. PubMed ID: 6389225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.